SCARDA: Japan’s New Vaccine R&D Center With $1.6bn Budget – But Where's The Goal?

Hopes But Some Concerns

 
• By Lisa Takagi
  
SCARDA will control innovative vaccine R&D projects in Japan.
SCARDA Will Control Innovative Vaccine R&D Projects In Japan • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Japan

More from Focus On Asia